{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T21:52:26Z","timestamp":1792101146922,"version":"4.4.0"},"reference-count":21,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Dermatology"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.clindermatol.2023.09.005","type":"journal-article","created":{"date-parts":[[2023,9,18]],"date-time":"2023-09-18T20:09:32Z","timestamp":1695067772000},"page":"721-728","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Unraveling the complexities of drug reaction with eosinophilia and systemic symptoms (DRESS): Insights into clinical, laboratory, and histopathologic features of a case series from an Italian tertiary center"],"prefix":"10.1016","volume":"41","author":[{"given":"Jan Walter","family":"Schroeder","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlotta","family":"Napoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Caputo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuela","family":"Bonoldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco","family":"Rongioletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clindermatol.2023.09.005_bib0001","doi-asserted-by":"crossref","first-page":"229","DOI":"10.18176\/jiaci.0480","article-title":"Spanish guidelines for diagnosis, management, treatment, and prevention of dress syndrome","volume":"30","author":"Caba\u00f1as","year":"2020","journal-title":"J Investig Allergol Clin Immunol"},{"key":"10.1016\/j.clindermatol.2023.09.005_bib0002","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.amjmed.2011.01.017","article-title":"The DRESS syndrome: a literature review","volume":"124","author":"Cacoub","year":"2011","journal-title":"Am J Med"},{"key":"10.1016\/j.clindermatol.2023.09.005_bib0003","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1111\/jdv.13728","article-title":"Coexistence of histopathological features is characteristic of drug reactions with eosinophilia and systemic symptoms and correlates with high grades of cutaneous abnormalities","volume":"30","author":"Cho","year":"2016","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2023.09.005_bib0004","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/bjd.13683","article-title":"Histopathology of drug rash with eosinophilia and systemic symptoms syndrome: a morphological and phenotypical study","volume":"173","author":"Ortonne","year":"2015","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2023.09.005_bib0005","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/j.jaad.2013.11.053","article-title":"Comments on: DRESS syndrome","volume":"71","author":"Kardaun","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2023.09.005_bib0006","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0172830","article-title":"Interrater agreement of two adverse drug reaction causality assessment methods: a randomised comparison of the Liverpool Adverse Drug Reaction Causality Assessment Tool and the World Health Organization-Uppsala Monitoring Centre system","volume":"12","author":"Mouton","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.clindermatol.2023.09.005_bib0007","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1111\/bjd.12501","article-title":"Drug reaction with eosinophilia and systemic symptoms (DRESS): an original multisystem adverse drug reaction. Results from the prospective RegiSCAR study","volume":"169","author":"Kardaun","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2023.09.005_bib0008","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.jaip.2018.08.013","article-title":"Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome identified in the electronic health record allergy module","volume":"7","author":"Wolfson","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.clindermatol.2023.09.005_bib0009","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.iac.2009.04.007","article-title":"The variable clinical picture of drug-induced hypersensitivity syndrome\/drug rash with eosinophilia and systemic symptoms in relation to the eliciting drug","volume":"29","author":"Kano","year":"2009","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.clindermatol.2023.09.005_bib0010","doi-asserted-by":"crossref","first-page":"7072","DOI":"10.3390\/ijms22137072","article-title":"Role of multiple comorbidities and therapies in conditioning the clinical severity of dress: a mono-center retrospective study of 25 cases","volume":"22","author":"Toniato","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.clindermatol.2023.09.005_bib0011","doi-asserted-by":"crossref","first-page":"943","DOI":"10.4103\/0366-6999.204104","article-title":"Drug reaction with eosinophilia and systemic symptoms","volume":"130","author":"Wang","year":"2017","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.clindermatol.2023.09.005_bib0012","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/j.jid.2016.02.808","article-title":"Impact of the HLA-B*58:01 allele and renal impairment on allopurinol-induced cutaneous adverse reactions","volume":"136","author":"Ng","year":"2016","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2023.09.005_bib0013","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1111\/jdv.18100","article-title":"Skin manifestations and clinical features of drug reaction with eosinophilia and systemic symptoms: a retrospective multicentre study of 125 patients","volume":"36","author":"Lee","year":"2022","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2023.09.005_bib0014","doi-asserted-by":"crossref","first-page":"4134","DOI":"10.1111\/bcp.15354","article-title":"A. Drug reaction with eosinophilia and systemic symptoms (DRESS): a tertiary care center retrospective study","volume":"88","author":"Del Pozzo-Maga\u00f1a","year":"2022","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.clindermatol.2023.09.005_bib0015","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.jaad.2021.04.020","article-title":"Discriminating minor and major forms of drug reaction with eosinophilia and systemic symptoms: facial edema aligns to the severe phenotype","volume":"85","author":"Momen","year":"2021","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2023.09.005_bib0016","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/5163129","article-title":"Recent advances in drug-induced hypersensitivity syndrome\/drug reaction with eosinophilia and systemic symptoms","volume":"2018","author":"Watanabe","year":"2018","journal-title":"J Immunol Res"},{"key":"10.1016\/j.clindermatol.2023.09.005_bib0017","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.jaad.2013.01.032","article-title":"DRESS syndrome: Part I. Clinical perspectives","volume":"68","author":"Husain","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2023.09.005_bib0018","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.jaad.2018.08.052","article-title":"Drug-induced hypersensitivity syndrome\/drug reaction with eosinophilia and systemic symptoms severity score: A useful tool for assessing disease severity and predicting fatal cytomegalovirus disease","volume":"80","author":"Mizukawa","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2023.09.005_bib0019","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1111\/j.1468-3083.2008.02585.x","article-title":"Clinicopathological features and prognosis of drug rash with eosinophilia and systemic symptoms: a study of 30 cases in Taiwan","volume":"22","author":"Chiou","year":"2008","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2023.09.005_bib0020","article-title":"Case reports of DRESS syndrome and symptoms consistent with DRESS syndrome following treatment with recently marketed monoclonal antibodies","volume":"9","author":"Di Palma-Grisi","year":"2019","journal-title":"Autoimmune Dis"},{"key":"10.1016\/j.clindermatol.2023.09.005_bib0021","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1134178","article-title":"Novel targeted inhibition of the IL-5 axis for drug reaction with eosinophilia and systemic symptoms syndrome","volume":"14","author":"Rubin","year":"2023","journal-title":"Front Immunol"}],"container-title":["Clinics in Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X23001438?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X23001438?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:21:44Z","timestamp":1760034104000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0738081X23001438"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":21,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["S0738081X23001438"],"URL":"https:\/\/doi.org\/10.1016\/j.clindermatol.2023.09.005","relation":{},"ISSN":["0738-081X"],"issn-type":[{"value":"0738-081X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Unraveling the complexities of drug reaction with eosinophilia and systemic symptoms (DRESS): Insights into clinical, laboratory, and histopathologic features of a case series from an Italian tertiary center","name":"articletitle","label":"Article Title"},{"value":"Clinics in Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clindermatol.2023.09.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}